Riskpilot← Back to searchSign inGet full accessJE Bio Oy
OYActiveY-tunnus 3172896-9Sepäntie 9Rental and operating of own or leased real estate · NACE 6820Est. 20205 employees
Revenue 2024
EUR 0
EBITDA margin
—
-145% vs 2023
Equity ratio
-19.5%
Financial strength
Net profit 2024
EUR -74K
-1129% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR -23K | -145% |
| Net profit | EUR -74K | -1129% |
| Total assets | EUR 363K | -17% |
| Equity | EUR -71K | -2806% |
| Employees | 5 | — |
Legal name
JE Bio Oy
Y-tunnus number
3172896-9
Legal form
Osakeyhtiö
NACE code
6820 · Rental and operating of own or leased real estate
Founded
24. marraskuuta 2020
Share capital
EUR 0
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Varastointi, muiden kiinteistöjen vuokraus, omien kiinteistöjen kauppa, rakennuspaikan valmistelutyöt, koneurakointi
Address
Sepäntie 9
Phone
+3580400485360
Email
jukkaklemola@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 151 | 742 | 543 | 0 |
| Staff expenses | −63 | −123 | −131 | −181 |
| EBITDA | 34 | 51 | 51 | −23 |
| Depreciation & amort. | −14 | −41 | −30 | −31 |
| EBIT | 20 | 10 | 21 | −54 |
| Net financials | −3 | −15 | −27 | −19 |
| Profit before tax | 17 | −5 | −6 | −74 |
| Tax | 3 | −0 | −0 | −0 |
| Net profit | 14 | −5 | −6 | −74 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 181 | 665 | 437 | 363 |
| Equity | 14 | 9 | 3 | −71 |
| Long-term debt | 90 | 471 | 257 | 200 |
| Short-term debt | 77 | 186 | 178 | 234 |
| Total debt | 167 | 656 | 434 | 434 |
EBITDA margin
-2298000.0%
This company
15.8%
Market median
-14544404% vs market
20212024
Equity ratio
-19.5%
This company
38.2%
Market median
-151% vs market
20212024
Return on equity
-7357400.0%
This company
18.4%
Market median
-39985970% vs market
20212024
Net profit margin
-7357400.0%
This company
8.1%
Market median
-90832199% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
6.12×
This company
0.62×
Market median
-887% vs market
20212024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-11-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JM Chief Executive Officer | Chief Executive Officer | 2020 |
PM Audit | Audit | 2023 |
VM Deputy Member | Deputy Member | 2023 |
JA Deputy auditor | Deputy auditor | 2023 |
| Former (1) | ||
JA Deputy Member | Deputy Member | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairperson | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JE Bio Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jukka Matias Klemola | Chief Executive Officer | 0 companies |
| Jarkko Antti Tapio Paavola | Deputy Member | 0 companies |
| Päivi Marjut Karhala | Audit | 0 companies |
| Ville Mikko Matias Klemola | Deputy Member | 0 companies |
| Juho Aslak Johannes Himanen | Deputy auditor | 0 companies |
| Eetu Kalervo Lahikainen | Chairperson | 0 companies |